TScan Therapeutics, Inc. (TCRX)
About TScan Therapeutics, Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $10.3M
- Net income
- -$129.8M
- Total assets
- $228.8M
- Market cap
- $51.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $51.9M
- Shares outstanding
- 259.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 16, 2021
TScan Therapeutics, Inc. (TCRX) Stock Price
- Reported a net loss of $129.8M in FY2025.
- Trading 92% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review TScan Therapeutics, Inc..
Write a review
News about TScan Therapeutics, Inc.
News & sentiment via Polygon.io
TScan Therapeutics, Inc.: frequently asked questions
Is TScan Therapeutics, Inc. an American company?
TScan Therapeutics, Inc. is a US-based company headquartered in Waltham, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is TScan Therapeutics, Inc. headquartered?
TScan Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
Is TScan Therapeutics, Inc. publicly traded?
Yes — TScan Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol TCRX on the NASDAQ.
What does TScan Therapeutics, Inc. do?
TScan Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
